扫描二维码关注“博士后招聘网”微信订阅号或微信搜一搜“博士后招聘网”关注我们。
当前位置: 博士后招聘网 > 国外博士后招聘 > iTeos Therapeutics招聘肿瘤免疫学方向博士后

iTeos Therapeutics招聘肿瘤免疫学方向博士后

信息来源:未知 | 作者:admin | 时间:2015-10-28 11:51

【简介】博士后招聘网整理分享“iTeos Therapeutics招聘肿瘤免疫学方向博士后”,浏览查询更多博士后招聘计划请访问博士后招聘网

iTeos Therapeutics (www.iteostherapeutics.com) is an innovative biotech company engaged in the discovery and development of novel medicines targeting the metabolism of tumour immune microenvironment for the treatment of cancer. iTeos Therapeutics is strategically partnered with Pfizer Inc. for the development of IDO1 and TDO2 inhibitors and for the identification of novel targets and is developing its own pipeline of targeted small molecules and biological therapies for immuno-oncology.

iTeos Therapeutics offers a culturally-diverse English-speaking work environment in the heart of Europe, in Belgium, few hours away from Europe’s capital cities.

iTeos Therapeutics has the ambition and the resources to grow to a worldwide class. In order to support this challenging growth, we are hiring a (m/f):

Post-doctoral Scientist ‐ Tumor Immunology

Responsibilities
We are seeking an independent, motivated and creative researcher for a postdoctoral position. The successful candidate will join a research team that investigates tumor immunology, tumor immune response and immune cell signaling in the tumor microenvironment. The selected candidate will be responsible for designing, conducting and coordinating key biological/pharmacological studies focused on the validation of novel targets.

Your main responsibilities are as follows:
• Design, perform and oversee the evaluation of new molecular targets and therapeutic agents
• Mentor and develop Research Assistants.
• Analyze, and present experimental results and present research updates to project teams and R&D management.
• Report experimental results to support regulatory filings, patents and publications.
• Maintain knowledge of scientific advances and competitive activity from scientific literature, meetings and academic/industrial contacts.

Profile
• PhD with a strong background in immunology, cell signaling and/or cancer biology ;
• Qualifications should be demonstrated by at least one first author paper published or accepted in a high-quality journal ;
• Strong experimental skills with demonstrated ability to execute well-designed decision-leading experiments ;
• Rigorous, detail‐oriented, committed and yet flexible ;
• Autonomous, self-driven and willing to constantly raise the bar ;
• Excellent verbal and written communication skills in English ;
• Strong team spirit and excellent interpersonal skills.

Offer
• A stimulating scientific position within a high‐potential innovative biotech company.
• Work in a science-driven, human size, dynamic, respectful and professional environment.
• The opportunity to be part of an exciting scientific and business endeavor and to learn about drug discovery.
• 2 – year position renewable for a third year.

Interested ?


Please send your CV together with an adapted cover letter via TBD to recruitment@pahrtners.be.

Ref : PostDoc – TI.
Your application will remain strictly confidential.

请您在邮件申请时在标题注明信息来自:博士后招聘网-boshihoujob.com,电话咨询时说明从博士后招聘网(www.boshihoujob.com)看到的博士后招聘信息。

声明:凡本网注明“来源:XXX”的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜,请与我们联系。邮箱:boshihoujob@163.com。

博士后招聘网微信公众号

博士后招聘网微信公众号

扫描二维码关注公众号,ID:boshihoujob

发布博士后招聘信息 加入博士人才库

博士&博士后社群

  • 博士后招聘1号群
    799173148

  • 博士后招聘2号群
    373726562

  • 哲学博士群
    934079716

  • 经济学博士群
    945762011

  • 法学博士群
    934096817

  • 教育学博士群
    934118244

  • 文学博士群
    934106321

  • 历史学博士群
    945803407

  • 理学博士群
    934102752

  • 工学博士群
    945827064

  • 农学博士群
    114347294

  • 医学博士群
    729811942

  • 管理学博士群
    797229360

Copyright©2018-2023 博士后招聘网(boshihoujob.com) 版权所有 皖ICP备18007485号-1 皖公网安备 34070202000340号

本网站所有资讯内容、广告信息,未经书面同意,不得转载。

博士后招聘网(www.boshihoujob.com)专注服务于海内外博士后研究人员。

博士后招收信息发布请联系邮箱boshihoujob@163.com,QQ:878065319,微信号:bshjob001。
联系时请注明单位名称(如:单位名称+博士后招收信息发布)。